| Catalog_no | ADMC0221 |
| Product_name | LY2835219(Abemaciclib) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1000.00/2120.00/2660.00 |
| Specificity | TargetTargets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Dilution | IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Purification | >99% |
| Concentration | 靶点：CDK;IC50： 2 nM (CDK4), 10 nM (CDK6) |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | LY2835219; LY-2835219; LY 2835219 |
| Observed_band | 602.7 |
| Notes | LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
| Instructions | 
查看与下载 |
| Share |
|
